Format

Send to

Choose Destination
Autophagy. 2013 Sep;9(9):1435-7. doi: 10.4161/auto.25722. Epub 2013 Jul 23.

MTORC1 determines autophagy through ULK1 regulation in skeletal muscle.

Author information

1
Biozentrum; University of Basel; Basel, Switzerland; Neuromuscular Research Center; Departments of Neurology and Biomedicine; Pharmazentrum; Basel University Hospital; Basel, Switzerland.

Abstract

Autophagy impairment has been implicated in several muscle disorders and in age-related dysfunction. Although previous reports pointed to FOXO as a positive regulator of autophagy in skeletal muscle, it remained unclear what is triggering autophagy. We found that TSC muscle knockout (TSCmKO) mice, characterized by specific depletion of TSC1 in skeletal muscle, and thus constant activation of MTORC1, develop a late-onset myopathy marked by the accumulation of autophagic substrates. In those mice, autophagy induction is blocked despite FOXO activation because of constant MTORC1-dependent inhibition of ULK1. Treatment of TSCmKO mice with rapamycin is sufficient to restore autophagy and to alleviate, at least in part, the myopathy. Inversely, inactivation of the MTORC1 pathway in RPTOR-depleted muscles triggers LC3B lipidation in spite of FOXO inhibition. In conclusion, MTORC1 constitutes the master regulator of autophagy induction in skeletal muscle and its deregulation leads to pathologic alterations of muscle homeostasis.

KEYWORDS:

FOXO; MTORC1; ULK1; atrophy; autophagy; myopathy; skeletal muscle

PMID:
23896646
DOI:
10.4161/auto.25722
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center